530 related articles for article (PubMed ID: 27459991)
21. Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of T cell responses.
Tribulatti MV; Figini MG; Carabelli J; Cattaneo V; Campetella O
J Immunol; 2012 Apr; 188(7):2991-9. PubMed ID: 22357632
[TBL] [Abstract][Full Text] [Related]
22. Varied expression and localization of multiple galectins in different cancer cell lines.
Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
[TBL] [Abstract][Full Text] [Related]
23. Transmembrane protein 147 (TMEM147): another partner protein of Haemonchus contortus galectin on the goat peripheral blood mononuclear cells (PBMC).
Li Y; Yuan C; Wang L; Lu M; Wang Y; Wen Y; Yan R; Xu L; Song X; Li X
Parasit Vectors; 2016 Jun; 9(1):355. PubMed ID: 27337943
[TBL] [Abstract][Full Text] [Related]
24. MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin.
Song Y; Wang P; Zhao W; Yao Y; Liu X; Ma J; Xue Y; Liu Y
Exp Cell Res; 2014 May; 324(1):54-64. PubMed ID: 24657544
[TBL] [Abstract][Full Text] [Related]
25. RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.
Dai B; Zhang P; Zhang Y; Pan C; Meng G; Xiao X; Wu Z; Jia W; Zhang J; Zhang L
Oncol Rep; 2016 Jul; 36(1):173-80. PubMed ID: 27176716
[TBL] [Abstract][Full Text] [Related]
26. Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line.
Dos Santos C; Karaky R; Renoir D; Hamma-Kourbali Y; Albanese P; Gobbo E; Griscelli F; Opolon P; Dalle S; Perricaudet M; Courty J; Delbé J
Int J Cancer; 2010 Sep; 127(5):1038-51. PubMed ID: 20013808
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration.
Hittelet A; Legendre H; Nagy N; Bronckart Y; Pector JC; Salmon I; Yeaton P; Gabius HJ; Kiss R; Camby I
Int J Cancer; 2003 Jan; 103(3):370-9. PubMed ID: 12471620
[TBL] [Abstract][Full Text] [Related]
28. Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines.
Safaee S; Fardi M; Hemmat N; Khosravi N; Derakhshani A; Silvestris N; Baradaran B
Molecules; 2021 Feb; 26(4):. PubMed ID: 33572092
[TBL] [Abstract][Full Text] [Related]
29. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
[TBL] [Abstract][Full Text] [Related]
30. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation.
Sturm A; Lensch M; André S; Kaltner H; Wiedenmann B; Rosewicz S; Dignass AU; Gabius HJ
J Immunol; 2004 Sep; 173(6):3825-37. PubMed ID: 15356130
[TBL] [Abstract][Full Text] [Related]
31. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
32. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
[TBL] [Abstract][Full Text] [Related]
33. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
Baba M; Wada J; Eguchi J; Hashimoto I; Okada T; Yasuhara A; Shikata K; Kanwar YS; Makino H
J Am Soc Nephrol; 2005 Nov; 16(11):3222-34. PubMed ID: 16177004
[TBL] [Abstract][Full Text] [Related]
34. Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
Takano J; Morishita A; Fujihara S; Iwama H; Kokado F; Fujikawa K; Fujita K; Chiyo T; Tadokoro T; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Mori H; Niki T; Hirashima M; Masaki T
Oncol Rep; 2016 Feb; 35(2):851-60. PubMed ID: 26717877
[TBL] [Abstract][Full Text] [Related]
35. Mammalian diaphanous-related formin 1 is required for motility and invadopodia formation in human U87 glioblastoma cells.
Li Z; Xu Y; Zhang C; Liu X; Jiang L; Chen F
Int J Mol Med; 2014 Feb; 33(2):383-91. PubMed ID: 24317603
[TBL] [Abstract][Full Text] [Related]
36. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
37. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
38. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells.
Li XT; Wang HZ; Wu ZW; Yang TQ; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Huang YL; Zhou YX; Du ZW
Cell Mol Neurobiol; 2015 Jul; 35(5):679-87. PubMed ID: 25662849
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanisms.
Zamykal M; Martens T; Matschke J; Günther HS; Kathagen A; Schulte A; Peters R; Westphal M; Lamszus K
Neuro Oncol; 2015 Aug; 17(8):1076-85. PubMed ID: 25543125
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.
Lahm H; André S; Hoeflich A; Fischer JR; Sordat B; Kaltner H; Wolf E; Gabius HJ
J Cancer Res Clin Oncol; 2001; 127(6):375-86. PubMed ID: 11414198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
